Genevieve Giguere joins Mantra Pharma as chief operating officer

BROSSARD, November 2, 2026 — Mantra Pharma is pleased to announce that Genevieve Giguere will join the company as Chief Operating Officer, effective November 9, 2026.

Brossard, April 30, 2026 – Through its partnership with Dr. Reddy’s, Mantra Pharma is proud to be the first company to receive a Notice of Compliance (NOC) from Health Canada for REDDY-Semaglutide, a generic of Ozempic®.

BROSSARD, April 24, 2026 – mcal® announces the launch of mcal® Calcium Citrate Powder for Oral Suspension, a new option designed to facilitate daily calcium administration, particularly in settings where ease of use and dosing accuracy are essential.

BROSSARD, April 2, 2026 — Mantra Pharma is proud to announce the acquisition of the Quebec-based company Cutimed, manufacturer of the Cutibase dermatological skincare line, well known among dermatologists and pharmacists and widely distributed in pharmacies across Quebec.

Effective December 15, 2025, Mantra Pharma Inc. will no longer be responsible for promoting Ulticare® products on behalf of Stericycle Inc.

BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J'ARRÊTE.

BROSSARD, January 20, 2025 – Mantra Pharma, a leading Quebec-based developer and marketer of generic medications, announces the upcoming launch of M-METFORMIN, an addition to its generic range.

We are delighted to share that Mantra Pharma proudly took part in the 2024 Noeudvembre campaign, organized by PROCURE. Held throughout November, this annual effort is dedicated to raising public awareness and funding critical research in the fight against prostate cancer, the most common cancer among men.